Determining Treatment Efficacy in the Treatment of Myasthenia Gravis
A. Gordon Smith, MD, FAAN, discusses how to assess for treatment success and why the patient perspective is so important in deciding whether to change therapies.
EP: 1.Prevalence and Pathophysiology of Myasthenia Gravis
EP: 2.Unmet Needs in the Management of Myasthenia Gravis
EP: 3.Standards of Care for Myasthenia Gravis
EP: 4.The Role of Monoclonal Antibodies in the Treatment of Myasthenia Gravis
EP: 5.The Fc Receptor and Mechanisms of Efgartigimod
EP: 6.Clinical Trial Data for Efgartigimod in the Treatment of Myasthenia Gravis
EP: 7.Evolving Approaches to Treatment Selection in the Management of Myasthenia Gravis
Now Viewing
EP: 8.Determining Treatment Efficacy in the Treatment of Myasthenia Gravis
EP: 9.Investigational Agents for the Treatment of Myasthenia Gravis
EP: 10.Collaborating With Primary Care Physicians for the Management of Patients With Myasthenia Gravis
Recent Videos
Related Content
